08/14/2026 | Press release | Distributed by Public on 08/14/2026 13:06
|

|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|

|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT
|
|
Utah
|
45-3672530
|
|
(State or other jurisdiction of
|
(I.R.S. Employer Identification No.)
|
|
incorporation or organization)
|
|
640 Belle Terre Rd. 2 E, Port Jefferson,
|
11777
|
|
NY
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large Accelerated filer
|

|
Accelerated filer
|

|
||
|
Non-accelerated filer
|

|
Smaller reporting company
|

|
||
|
Emerging growth company
|

|
|
Cautionary Note Regarding Forward-Looking Statements
|
2
|
|
Part I - FINANCIAL INFORMATION
|
4
|
|
|
|
|
Item 1. Financial Statements
|
4
|
|
Condensed Balance Sheets
|
4
|
|
Condensed Statements of Operations
|
5
|
|
Condensed Statements of Stockholders' Deficit
|
6
|
|
Condensed Statements of Cash Flows
|
7
|
|
Notes to the Condensed Financial Statements
|
8
|
|
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
|
17
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
|
20
|
|
Item 4. Controls and Procedures.
|
20
|
|
PART II -OTHER INFORMATION
|
21
|
|
|
|
|
Item 1. Legal Proceedings
|
21
|
|
Item 1A. Risk Factors
|
21
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
29
|
|
Item 3. Defaults Upon Senior Securities.
|
29
|
|
Item 4. Mine Safety Disclosure
|
29
|
|
Item 5. Other Information.
|
29
|
|
Item 6. Exhibits
|
30
|
| 1 |
| 2 |
| 3 |
|
June 30,
|
||||||||
|
2026
(unaudited)
|
December 31,
2025
|
|||||||
|
ASSETS
|
||||||||
|
Current assets
|
||||||||
|
Cash
|
$
|
5,409
|
$
|
661
|
||||
|
Prepaid expenses
|
7,500
|
7,250
|
||||||
|
Total current assets
|
12,909
|
7,911
|
||||||
|
Total assets
|
$
|
12,909
|
$
|
7,911
|
||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
Current liabilities
|
||||||||
|
Accounts payable
|
$
|
33,909
|
$
|
48,203
|
||||
|
Accounts payable - related party
|
477
|
477
|
||||||
|
Convertible note payable
|
100,000
|
100,000
|
||||||
|
Notes payable - related party
|
122,500
|
112,500
|
||||||
|
Accrued expenses
|
23,509
|
18,009
|
||||||
|
Total current liabilities
|
280,395
|
279,189
|
||||||
|
Long-term liabilities
|
-
|
-
|
||||||
|
Total liabilities
|
280,395
|
279,189
|
||||||
|
Commitments and contingencies
|
-
|
-
|
||||||
|
Stockholders' deficit
|
||||||||
|
Preferred stock; $0.001 par value; 10,000,000 authorized; no shares issued and outstanding, as of June 30, 2026 and December 31, 2025, respectively.
|
-
|
-
|
||||||
|
Common stock; $0.001 par value; 90,000,000 authorized; 83,548,469 and 83,548,469 shares issued and outstanding, as of June 30, 2026 and December 31, 2025, respectively.
|
83,549
|
83,549
|
||||||
|
Additional paid-in capital
|
9,594,687
|
9,594,687
|
||||||
|
Accumulated deficit
|
(9,945,722
|
)
|
(9,949,514
|
)
|
||||
|
Total stockholders' deficit
|
(267,486
|
)
|
(271,278
|
)
|
||||
|
Total liabilities and stockholders' deficit
|
$
|
12,909
|
$
|
7,911
|
||||
| 4 |
|
Three months
ended
June 30, 2026
|
Three months
ended
June 30, 2025
|
Six months
ended
June 30, 2026
|
Six months
ended
June 30, 2025
|
|||||||||||||
|
Revenue
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||||
|
Operating expenses
|
||||||||||||||||
|
General and administrative expense
|
8,073
|
5,469
|
12,906
|
11,174
|
||||||||||||
|
Rent expense
|
210
|
-
|
610
|
-
|
||||||||||||
|
Professional and consulting fees
|
14,273
|
4,950
|
22,192
|
17,945
|
||||||||||||
|
Total operating expenses
|
22,556
|
10,419
|
35,708
|
29,119
|
||||||||||||
|
Operating Loss
|
(22,556
|
)
|
(10,419
|
)
|
(35,708
|
)
|
(29,119
|
)
|
||||||||
|
Other
income (expense)
|
|
|
||||||||||||||
|
Other income
|
45,000
|
-
|
45,000
|
|||||||||||||
|
Interest expense
|
(2,774
|
)
|
(1,246
|
)
|
(5,500
|
)
|
(2,479
|
)
|
||||||||
|
Total other income (expense)
|
42,226
|
(1,246
|
)
|
39,500
|
(2,479
|
)
|
||||||||||
|
Net income (loss) before income tax
|
19,670
|
(11,665
|
)
|
3,792
|
(31,598
|
)
|
||||||||||
|
Income tax expense
|
-
|
-
|
-
|
-
|
||||||||||||
|
Net income (loss)
|
$
|
19,670
|
$
|
(11,665
|
)
|
$
|
3,792
|
$
|
(31,598
|
)
|
||||||
|
Basic and diluted income (loss) per share
|
$
|
0.00
|
$
|
(0.00
|
)
|
$
|
0.00
|
$
|
(0.00
|
)
|
||||||
|
Weighted average common shares outstanding - basic and diluted
|
83,548,469
|
83,548,469
|
83,548,469
|
83,548,469
|
||||||||||||
| 5 |
|
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
deficit
|
Total
|
||||||||||||||||||||||
|
Balance, January 1, 2026
|
-
|
$
|
-
|
83,548,469
|
$
|
83,549
|
$
|
9,594,687
|
$
|
(9,949,514
|
)
|
$
|
(271,278
|
)
|
||||||||||||||
|
Net loss for the three months ended March 31, 2026
|
-
|
-
|
-
|
-
|
-
|
(15,878
|
)
|
(15,878
|
)
|
|||||||||||||||||||
|
Balance, March 31, 2026
|
-
|
-
|
83,548,469
|
83,549
|
9,594,687
|
(9,965,392
|
)
|
(287,156
|
||||||||||||||||||||
|
Net income for the three months ended June 30, 2026
|
-
|
-
|
-
|
-
|
-
|
19,670
|
19,670
|
|||||||||||||||||||||
|
Balance, June 30, 2026
|
-
|
$
|
-
|
83,548,469
|
$
|
83,549
|
$
|
9,594,687
|
$
|
(9,945,722
|
)
|
$
|
(267,486
|
)
|
||||||||||||||
|
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
deficit
|
Total
|
||||||||||||||||||||||
|
Balance, January 1, 2025
|
-
|
$
|
-
|
83,548,469
|
$
|
83,549
|
$
|
9,594,687
|
$
|
(9,893,332
|
)
|
$
|
(215,096
|
)
|
||||||||||||||
|
Net loss for the three months ended March 31, 2025
|
-
|
-
|
-
|
-
|
-
|
(19,933
|
)
|
(19,933
|
)
|
|||||||||||||||||||
|
Balance, March 31, 2025
|
-
|
-
|
83,548,469
|
83,549
|
9,594,687
|
(9,913,265
|
)
|
(235,029
|
)
|
|||||||||||||||||||
|
Net loss for the three months ended June 30, 2025
|
-
|
-
|
-
|
-
|
-
|
(11,665
|
)
|
(11,665
|
)
|
|||||||||||||||||||
|
Balance, June 30, 2025
|
-
|
$
|
-
|
81,548,469
|
$
|
83,549
|
$
|
9,594,687
|
$
|
(9,924,930
|
)
|
$
|
(246,694
|
)
|
||||||||||||||
| 6 |
|
Six months
ended
June 30,
2026
|
Six months
ended
June 30,
2025
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income (loss)
|
$
|
3,792
|
$
|
(31,598
|
)
|
|||
|
Adjustment to reconcile net income (loss) to net cash used in operating activities:
|
||||||||
|
Prepaid expenses
|
(250
|
)
|
(300
|
)
|
||||
|
Accounts payable
|
(14,294
|
)
|
12,164
|
|||||
|
Accounts payable-related party
|
-
|
19,450
|
||||||
|
Accrued expense
|
5,500
|
(1,226
|
)
|
|||||
|
Net cash used in operating activities
|
(5,252
|
)
|
(1,510
|
)
|
||||
|
Cash flows from investing activities:
|
||||||||
|
Net cash provided by investing activities
|
-
|
-
|
||||||
|
Cash flows from financing activities
|
||||||||
|
Net cash provided by financing activities
|
10,000
|
-
|
||||||
|
Net change in cash
|
4,748
|
(1,510
|
)
|
|||||
|
Cash at beginning of period
|
661
|
2,373
|
||||||
|
Cash at end of period
|
$
|
5,409
|
$
|
863
|
||||
|
Supplemental schedule of cash flow information
|
||||||||
|
Cash paid for interest
|
$
|
-
|
$
|
-
|
||||
|
Cash paid for income tax
|
$
|
-
|
$
|
-
|
||||
| 7 |
|
1.
|
Identify the contract with a customer.
|
|
2.
|
Identify the performance obligations in the contract.
|
|
3.
|
Determine the transaction price.
|
|
4.
|
Allocate the transaction price to the performance obligations in the contract.
|
|
5.
|
Recognize revenue when, or as, the reporting organization satisfied a performance obligation.
|
| 8 |
| 9 |
|
June 30, 2026
|
December 31, 2025
|
|||||||
|
Computer and office equipment
|
$
|
83,893
|
$
|
83,893
|
||||
|
Accumulated depreciation
|
(83,893
|
)
|
(83,893
|
)
|
||||
|
Total Property and Equipment
|
$
|
-
|
$
|
-
|
||||
| 10 |
|

|
Designated Shares
:
A total of 1,000,000 shares were designated as Series X Super Voting Preferred Stock, par value $0.001 per share, out of 10,000,000 shares of authorized preferred stock.
|
|

|
Dividends
:
The holders of Series X Preferred Stock are not entitled to receive dividends or to participate in dividends paid on common stock.
|
|

|
Liquidation Preference
:
None.
|
|

|
Voting Rights
:
Each share of Series X Preferred Stock votes 100 votes per share, voting together with the common stock (and any other generally-voting class) as a single class on all matters, except as otherwise required by law.
|
|

|
Conversion Rights
:
Holders have no right to convert Series X Preferred Stock into common stock. The shares are exempt from any reduction in the event of a future reverse stock split.
|
|

|
Redemption
:
Not redeemable.
|
| 11 |
|

|
Designated Shares
:
Of the Company's 10,000,000 authorized shares of preferred stock, par value $0.001 per share, 9,000,000 shares are designated as Series A Preferred Stock.
|
|

|
Dividends
:
Holders of Series A Preferred Stock are not entitled to receive dividends, nor to participate in any dividends paid on the Company's common stock.
|
|

|
Liquidation Preference
:
Holders of Series A Preferred Stock are not entitled to any liquidation preference.
|
|

|
Voting Rights
:
Each share of Series A Preferred Stock carries 20 votes per share, limited by the Maximum Percentage (defined below). The Series A Preferred Stock votes together with the common stock (and any other voting class or series) as a single class on all matters, except as otherwise required by law. The voting rights are not adjusted for any reverse stock splits of the Company's common stock.
|
|

|
Conversion Rights
:
Each share of Series A Preferred Stock is convertible into, or exchangeable for, 20 shares of common stock. The conversion ratio is not subject to adjustment for any future reverse stock split. In accordance with the Amended and Restated Certificate of Designation, each holder is prohibited from converting Series A Preferred Stock into common stock to the extent that such conversion would result in the holder owning more than 4.999% of the Company's then outstanding common stock (the "
Maximum Percentage
"), which Maximum Percentage may be increased to up to 9.999% upon 61 days written notice from any holder thereof.
|
|

|
Redemption
:
The Series A Preferred Stock is not redeemable.
|
| 12 |
| 13 |
| 14 |
| 15 |
| 16 |
| 17 |
| 18 |
| 19 |
| 20 |
| 21 |
| 22 |
| 23 |
|
●
|
"
short squeezes
";
|
|
●
|
comments by securities analysts or other third parties, including blogs, articles, message boards and social and other media;
|
|
●
|
large stockholders exiting their position in our securities or an increase or decrease in the short interest in our securities;
|
|
●
|
actual or anticipated fluctuations in our financial and operating results;
|
|
●
|
the recruitment or departure of key personnel;
|
|
●
|
actual or anticipated changes in estimates as to financial results, operational timelines or recommendations by securities analysts;
|
|
●
|
the timing and outcome of our business plan;
|
|
●
|
significant lawsuits or stockholder litigation;
|
|
●
|
variations in our financial results or those of companies that are perceived to be similar to us;
|
|
●
|
general economic, political, and market conditions and overall fluctuations in the financial markets in the U.S. and abroad; and
|
|
●
|
investors' general perception of us and our business.
|
| 24 |
| 25 |
|
●
|
If a "
penny stock
" is sold to the investor in violation of the requirements listed above, or other Federal or states securities laws, the investor may be able to cancel the purchase and receive a refund of the investment.
|
|
●
|
If a "
penny stock
" is sold to the investor in a fraudulent manner, the investor may be able to sue the persons and firms that committed the fraud for damages.
|
| 26 |
|
●
|
the difficulty of integrating acquired products, services or operations;
|
|
●
|
the potential disruption of the ongoing businesses and distraction of our management and the management of acquired companies;
|
|
●
|
difficulties in maintaining uniform standards, controls, procedures and policies;
|
|
●
|
the potential impairment of relationships with employees and customers as a result of any integration of new management personnel;
|
|
●
|
the potential inability or failure to achieve additional sales and enhance our customer base through cross-marketing of the products to new and existing customers;
|
|
●
|
the effect of any government regulations which relate to the business acquired;
|
|
●
|
potential unknown liabilities associated with acquired businesses or product lines, or the need to spend significant amounts to retool, reposition or modify the marketing and sales of acquired products or operations, or the defense of any litigation, whether or not successful, resulting from actions of the acquired company prior to our acquisition; and
|
|
●
|
potential expenses under the labor, environmental and other laws of various jurisdictions.
|
| 27 |
| 28 |
| 29 |
|
Exhibit
|
Filed/
Furnished
|
Incorporated By Reference
|
||||||||||
|
Number
|
Description of Exhibit
|
Herewith
|
Form
|
Exhibit
|
Filing
Date
|
File Number
|
||||||
|
2.1+
|
8-K
|
2.1
|
6/30/2026
|
000-54808
|
||||||||
|
3.1
|
8-K
|
3.1
|
6/30/2026
|
000-54808
|
||||||||
|
3.2
|
8-K
|
3.2
|
6/30/2026
|
000-54808
|
||||||||
|
3.3
|
8-K
|
3.3
|
7/10/2026
|
000-54808
|
||||||||
|
10.1£
|
8-K
|
10.1
|
6/30/2026
|
000-54808
|
||||||||
|
10.2
|
8-K
|
10.2
|
7/10/2026
|
000-54808
|
||||||||
|
10.3
|
8-K
|
10.3
|
7/10/2026
|
000-54808
|
||||||||
|
10.4†
|
8-K
|
10.4
|
7/10/2026
|
000-54808
|
||||||||
|
10.5†
|
8-K
|
10.5
|
7/10/2026
|
000-54808
|
||||||||
|
31.1*
|
|
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
|
|
[X]
|
|
|
|
|
|
|||
|
31.2*
|
|
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
|
|
[X]
|
|
|
|
|
||||
|
32.1**
|
|
Certification of Principal Officer Pursuant and Principal Financial Officer to Section 906 of the Sarbanes-Oxley Act
|
|
[X]
|
|
|
|
|
|
|
|
|
|
101.INS*
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
[X]
|
||||||||||
|
101.SCH*
|
XBRL Taxonomy Extension Schema Document
|
[X]
|
||||||||||
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
[X]
|
||||||||||
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document
|
[X]
|
||||||||||
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase Document
|
[X]
|
||||||||||
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
[X]
|
||||||||||
|
104*
|
Inline XBRL for the cover page of this Quarterly Report on Form 10-Q included in the Exhibit 101 Inline XBRL Document Set
|
[X]
|
||||||||||
| 30 |
|
NU-MED PLUS, INC.,
|
||
|
(Registrant)
|
||
|
August 14, 2026
|
By:
|
/s/ William Hayde
|
|
William Hayde, Chief Executive Officer
(Principal Executive Officer)
|
||
|
August 14, 2026
|
By:
|
/s/Keith L. Merrell
|
|
Keith L. Merrell, Chief Financial Officer
(Principal Financial/Accounting Officer)
|
||
| 31 |